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Abstract 
The method of bone-anchored attachment of limb prostheses via a percutaneous skeletal 
extension was developed to circumvent commonly reported problems associated with the 
conventional method of socket attachment. In addition to the direct structural connection, the 
percutaneous implant may serve as a conduit for bidirectional communication between muscles 
and nerves within the residual limb and the prosthesis. Implanted electrodes recording 
myoelectric activity within the residual limb can be used to infer the user’s movement intent 
and may thus be used to provide intuitive control of the prosthesis in real time. Sensory 
feedback from the prosthesis can be provided back to the user by neurostimulation via 
implanted neural electrodes, thus closing the control loop. Together the skeletal, neural, and 
muscular interfaces form a neuromusculoskeletal interface. This technology is currently being 
evaluated in a clinical trial on individuals with upper limb amputation, but it has not yet been 
used in the lower limb.  
The aim of this thesis has been to translate the concept of neuromusculoskeletal interfacing to 
the lower limb. An additional aim has been to reduce the limitations on high impact activities, 
that exist on current available systems for bone-anchored attachment of limb prostheses. To 
achieve these aims, a new design of the neuromusculoskeletal interface was developed where 
the structural capacity was increased with respect to current versions of the implant system to 
accommodate increased loads for highly active usage by individuals with lower limb 
amputation. In order to set adequate design requirements, investigations were conducted to 
determine the load exposure of bone-anchored implant systems during a number of loadbearing 
activities. Structural verification of the neuromusculoskeletal interface has been performed 
using numerical simulations as well as physical testing in static and dynamic conditions. The 
first steps towards clinical implementation of the lower limb neuromusculoskeletal interface 
have been taken by the development of a clinical research protocol that has been approved by 
the Swedish Ethical Review Authority. 
 
Keywords: Osseointegration; neuromusculoskeletal interface, bone-anchored attachment, 
direct skeletal attachment, Osseointegrated Prostheses for the Rehabilitation of Amputees 
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In order to describe the scope of this thesis, some introductory information is first given in this 
chapter.  
1.1. Conventional suspension of prosthetic limbs  
The conventional method for attachment of a limb prosthesis to the body is via a socket which 
compresses the soft tissues of the residual limb. However, the socket connection is the source 
of many of the commonly reported problems for prosthesis users, such as discomfort, skin 
problems, perspiration and poor fit [1]–[6]. A reason for this is the high compressive and 
frictional forces required for adequate retention of the prosthesis and the difficulty to achieve 
a good fit between the socket and the residual limb. These problems may limit the prosthesis 
usage, reduce the ability to ambulate with the prosthesis, and lead to reduced participation in 
social activities [3], [4], [6], [7]. For individuals with a short residual limb, skin disorders, 
heterotopic ossification, or other conditions which affect the residual limb, a socket may not 
be a viable option. These individuals may be relegated to a wheelchair and/or abandon their 
artificial limb. It was to address these issues that the concept of bone-anchored attachment of 
limb prostheses was developed.  
 
1.2. Bone-anchored attachment of prosthetic limbs and the OPRA Implant System 
Bone-anchoring of prostheses is a concept in which a percutaneous skeletal extension of the 
residual bone is created, allowing for attachment of a prosthesis without a socket. The method 
builds on the discovery that bone tissue may form an exceptionally intimate and mechanically 
stable connection with titanium [8]. This phenomenon is now known as osseointegration and 
is defined as “the firm anchoring of a surgical implant by the growth of bone around it without 
fibrous tissue formation at the interface” [9]. The first clinical applications of osseointegration 
were in dental field, but it has since then spread to other applications such as hearing aids, facial 
reconstructions and orthopedic applications including bone-anchored attachment of prosthetic 
limbs [10]. The method was developed in Sweden and the Swedish system for bone-anchored 
attachment of prosthetic limbs, known as the OPRA (Osseointegrated Prostheses for the 
Rehabilitation of Amputees) Implant System (Integrum AB, Mölndal) is a market leader for 
this application.  
 
1.3. e-OPRA Implant System 
Beyond the attachment of the prosthesis to the skeleton, bone-anchored attachment also opens 
up for further integration between the prosthesis and the human body. A recent enhancement 
of the OPRA Implant System for upper limb users has led to a neuromusculoskeletal interface 
known as the e-OPRA Implant System, where in addition to the skeletal attachment, a direct 
connection with muscles and nerves within the residual limb is also achieved via implanted 
electrodes [11], [12]. This allows for the recording of electromyographic (EMG) signals from 
the muscles in the residual limb. With the recorded signals the prosthesis can be volitionally 
controlled by the user [13]–[15]. Furthermore, sensors on the prosthesis are in direct contact 




response to external stimuli of the prosthesis [16]. This means that the user can perceive 
sensations with their prosthesis in the same way as with an intact limb. The proven success of 
the e-OPRA Implant System in the upper limb [12] may be attainable also for the lower limb. 
If realized, this has the potential to substantially push the frontier of prosthetic control of lower 
limb prostheses, as it would provide the first permanent, stable neuromusculoskeletal interface 
in individuals with lower limb amputation. With this interface, one of the largest barriers 
preventing neural control of lower limb prostheses from becoming clinically feasible would be 
removed.  
 
1.4. Need for further development 
The current version of the OPRA Implant System for the lower limb is designed for, and 
functions well in activities of everyday living, but for safety reasons, there are restrictions on 
high impact activities. For example, it is advised against running and jumping with the 
prosthesis attached to the implant. Additionally, the highest body weight acceptable for 
treatment with the OPRA Implant System is 100 kg. For conservative reasons, the treatment 
has primarily been recommended for individuals who have or are expected to have problems 
with a conventional socket attachment. Since there are not many individuals with a 
transfemoral amputation who would be able to run with a standard prosthesis in the first place, 
the activity limitations are not very restrictive. However, it has been shown that bone-anchored 
attachment of limb prostheses often leads to increased mobility and prosthesis usage [17]–[19] 
and with this increased capability comes a desire to perform more demanding activities. 
Furthermore, if current indications for use of the OPRA Implant System were to be updated 
based on positive clinical results, more active individuals with a desire to go beyond the 
limitations of the current implant system would be prospective candidates for the treatment. 
Recent developments of more advanced prosthetic legs, some of which have the capability to 
provide additional joint torques during loadbearing to compensate for lost musculature, will 
increase the demands on the strength of the implant system. It is believed that these types of 







2. Scope of thesis 
The aim of this thesis was to introduce the neuromuscular interface of the e-OPRA Implant 
System to users with lower limb amputation and to simultaneously reduce the limitations on 
high impact loading that are currently placed on implant systems for bone-anchored attachment 
of prosthetic limbs. To achieve these objectives, this thesis project sought to:  
• Increase the structural capacity the OPRA Implant System so that it can tolerate lower 
limb prosthetic usage at load levels beyond those associated with activities of daily 
living.  
 
• Translate the neuromuscular interface of the e-OPRA Implant System for upper limb 
to the implant system for the lower limb. 
 
• Prepare for clinical implantation of the developed system within a clinical investigation.  
 
 
Within the scope of these objectives the following research questions have been addressed. 
• What are the mechanical and biomechanical characteristics of implant systems that 
have showed successful results for bone-anchored attachment of limb prostheses? 
 
• What is the load exposure of bone-anchored implants for amputation prostheses and 
surrounding bone during use?  
 
• What would the load exposure of the bone-anchored implant and surrounding bone be 
if subjected to high loading activities which are beyond the recommendations of current 
implant systems? 
 
• How is the loadbearing capacity of the bone-anchored implant affected by the 
surrounding bone tissue? 
 
• How do geometrical design features affect the structural capacity of the bone-anchored 
implant system?  
 
• To what extent can surface enhancement methods influence the structural endurance of 
the bone-anchored implant system?   
 
 













3.1. Socket attachment of prosthetic limbs 
The aim of a lower limb prosthesis is to restore the functions of the missing foot and leg of 
which the most important are bodily support, balance, and means of ambulation. The prosthesis 
is most commonly attached to the body via a socket which compresses the soft tissues of the 
residual limb. The prosthesis is kept in place via frictional forces between the socket and the 
residual limb. In the case of lower limb amputation, the prosthetic retention must withstand 
considerable forces and moments since the prosthetic leg is loaded with the full body weight 
of the user during ambulation [20]–[22]. This demands that the prosthetic socket has a good fit 
to the residual limb, high friction coefficients and substantial normal forces between the socket 
and the skin to prevent relative sliding at the interface. The socket fit may be negatively affected 
by residual limb volume changes due to edema, atrophy or changes in body composition, [23]. 
Volume changes may also occur temporarily due to changes in environmental conditions such 
as temperature and humidity, or as a consequence of muscle contractions within the residual 
limb during ambulation. Environmental factors and the activity level may affect the friction 
coefficients due to perspiration and the dryness of the skin. These factors can make it difficult 
to obtain a consistently good fit between the socket and the residual limb. For individuals with 
a short residual limb, skin disorders, heterotopic ossification, or other conditions which affects 
the residual limb, it may be very difficult to achieve a functional prosthetic attachment using a 
socket. Even in the absence of these conditions, pressure sores from excessive and prolonged 
pressure on certain parts of the soft tissue, blisters originating from the residual limb pistoning 
within the socket, or rashes from a humid contained environment can all result from sub-
optimal socket attachment of the leg prosthesis and may lead to pain and reduced prosthesis 
usage [1]–[6]. 
  
3.2. Lower limb prostheses 
A transfemoral prosthesis consists of separate knee and foot prostheses and a prosthetic pylon 
to connect the two to form a prosthetic leg. Knee prostheses can be divided into mechanical 
knees or microprocessor-controlled knees (MPK). Mechanical knees (sometimes also referred 
to as non-microprocessor knees) are entirely passive and the impedance of the knee joint is 
controlled by friction, hydraulics or a mechanical locking mechanism. In MPKs on the other 
hand, the joint impedance is dynamically adjusted by a microprocessor, based on kinematic 
and force/torque data received from sensors on the prosthesis. MPKs may be further divided 
into energetically passive MPKs or active MPKs, where only the latter provides net positive 
power to the user. Such energy output from the knee joint is required to be able to naturally 
perform activities such as stair and slope ascension or raising from a seated position. At the 
writing of this thesis, the only commercially available active MPK is the PowerKnee from 
Össur, Iceland. However, extensive research is being conducted on several other active 
prosthetic legs by numerous research groups, examples are the Open Source Leg developed at 
the University of Michigan, MI, USA [24], the Cyberlegs developed at Vrije University in 
Brussels, Belgium [25], [26], the Vanderbilt knee and ankle prostheses [27], [28] developed at 
Vanderbilt University in Nashville, TN, USA, the Hybrid knee developed at Research Institute 




developed at Massachusetts Institute of Technology, MA, USA [29]–[32]. Prosthetic feet may 
be categorized as non-articulated feet or articulated feet, where non-articulated feet may be 
further subdivided into solid ankle cushion heel (SACH) feet or energy storage and return 
(ESAR) feet. The SACH foot has a solid keel which does not provide any aid during the push-
off phase of the gait cycle. ESAR feet have a leaf spring function achieved by molded carbon 
fiber plates which are compressed by the body weight of the user during the stance phase and 
then spring back to return energy to the user for propulsion. Articulated feet may be either 
single axis or multi-axis, to enable plantar-dorsiflexion only or a combination of plantar-
dorsiflexion and inversion-eversion. Analogous to prosthetic knees, a subset of the articulated 
feet is microprocessor controlled prosthetic feet (MPF). As with the knee prostheses, the MPFs 
may be either passive or active. There is currently only one active MPF commercially available, 
Empower (formerly known as BioM) by Ottobock, Germany. 
 
3.3. Lower limb prosthetic control 
The lower limb movements during ambulation are cyclic in nature but vary between ambulation 
modes (e.g., level ground walking, stairs, ramp etc.). An ambulation mode may be divided into 
phases for example as indicated in Figure 2.  
 
Figure 2. The figure (reproduced with permission from Stöckel et al. 2015 [33]) shows the functional gait phases 
as defined by Perry and Burnfield 2010 [34].  
 
In MPKs, the microprocessor uses sensor data to determine current gait phase and adjusts the 
impedance in real time according to predefined desired values for that gait phase. How the 
predefined desired values of the impedance vary with the gait phase is dependent on the 
ambulation mode. In order to determine the ambulation mode or detect transitions between 
ambulation modes, a high-level control scheme is used. This high-level control scheme may 
use additional data from sensors on the prosthesis, sensors placed on the sound limb, or 




mode or transitions between different modes. If these detections can be consistently correctly 
performed, then the prosthesis user may ambulate with seamless transitions between different 
ambulation modes. For active MPKs the same control strategy may employed but with the knee 
torque as an additional variable. Active prosthetic components increase the number of possible 
ambulation modes and thus increases the complexity of the control scheme.  
For non-cyclic movements, other control schemes based on direct control or pattern recognition 
may be used. The use of EMG data from the residual limb to control the prosthesis is a standard 
practice in upper limb prostheses but it is not yet commercially available for the control of 
lower limb prostheses despite research efforts with promising results [35]–[39]. One reason for 
this may be increased difficulties to achieve robust EMG signals due to instabilities in the skin-
to electrode interface for example as a consequence of socket pistoning (i.e., the displacement 
of the residual limb relative to the socket in the distal-proximal direction). Another reason may 
be that many activities of daily living (e.g., ambulation) follow well-defined cyclic patterns 
which to a certain extent makes them possible to predict even in the absence of input from 
biological sensors.  
 
3.4. Bone-anchored attachment of prosthetic limbs 
It was to address the inherent problems associated with the socket attachment, that the method 
of bone-anchored attachment of prosthetic limbs was developed. With this concept, a 
percutaneous skeletal extension is created in a surgical procedure where an implant is placed 
with its proximal end inserted into the remainder of the residual bone and its distal end 
protruding through the skin. The prosthesis can then be attached directly to the external portion 
of the implant, thus eliminating the need for a socket. The first fully successful clinical attempt 
of this method dates back to 1990 when an individual with bilateral transfemoral amputation 
was treated with this method in Gothenburg, Sweden [40]. The positive result owes a large part 
of its success to osseointegration. The phenomenon, first coined by Brånemark et al. in 1977 
[41] had been discovered already in the early 1960s by observing that bone tissue could form 
an exceptionally intimate and mechanically stable connection with titanium [8]. The first 
application of osseointegration was in the dental field, but it has since then spread to other 
applications such as hearing aids, facial reconstructions and orthopedic applications [10].  
Accumulated knowledge from osseointegration in the dental field, meticulous research on the 
biomechanical characteristics of osseointegration [42]–[46] and the initial experiences of bone-
anchored attachment of limb prostheses led to refinement of the implanted components and a 
standardized treatment protocol. The implant system received a CE-mark under the product 
name OPRA Implant System, manufactured by Integrum AB, Mölndal, Sweden. The system 
is CE-marked for transfemoral, transhumeral and thumb/finger amputations but custom-made 
implants are available for the aforementioned levels, as well as for transtibial and transradial 
amputations. The treatment has gained increasing clinical acceptance and is currently available 
in 12 countries. The OPRA Implant System was recently granted a premarket approval (PMA) 
by the Food and Drug Administration (FDA) in the USA for treatment at the transfemoral level.   
Following the successful results in Sweden, another implant system was independently 
developed in Germany under the name of ILP (Integral Leg Prosthesis, ESKA Orthopaedic 




first patient was treated with the ILP implant system, which is now in clinical use in Germany, 
the Netherlands, and Australia. Another system, based on the ILP design, was developed in 
Australia under the name of OPL (Osseointegrated Prosthetic Limb, Permedica s.p.a., Milan, 
Italy). This system is also clinically available in the Netherlands where it is called OFP 
(Osseointegrated Femur Prosthesis) or OTP (Osseointegrated Tibia Prosthesis) (manufactured 
by OTN Implants BV, The Netherlands). To date OPRA, ILP, and OPL are the only 
commercially available systems for direct skeletal attachment of external limb prostheses 
(Figure 3).  
 
Figure 3. The figure (adapted with permission from Thesleff et al. 2018 [47] (Paper I)) shows commercially 
available implant systems for bone-anchored attachment of prosthetic limbs. (A) Schematic image of OPRA 
Implant System in an amputated limb. (B) OPRA Fixture; the exterior surface in the dark grey region is treated 
to enhance osseointegration. The lower image shows a close-up of the laser-induced micro structure from the 
surface treatment. (C) Schematic image of the ILP implant system. (D) Close-up of the spongiosa metal surface 
to enhance osseointegration and ingrowth. (E) ILP implant system assembled. (F) Exploded view of ILP implant 
system assembly. (G) OPL type-B implant system.  
 
A number of other systems have reached the stage of clinical experiments in humans. These 
are the ITAP (Intraosseous Transcutaneous Amputation Prosthesis, Stanmore Implants 
Worldwide, Watford, United Kingdom) developed in the United Kingdom, the KWA (Keep 
Walking Advanced, Tequir S.L., Valencia, Spain) developed in Spain, and two systems 
developed in the United States: POP (Percutaneous Osseointegrated Prosthesis, DJO Global, 





Figure 4. The figure has been adapted with permission from Thesleff et al. 2018 [47] (Paper I). The figure shows 
implant systems for bone-anchored attachment of prosthetic limbs which have been successfully used in human 
subjects but are not commercially available. (A) Schematic illustration and exploded view of the POP system. (B) 
Schematic illustration of the ITAP system. (C) Schematic illustration of the KWA system. (D) Radiograph and 
schematic illustration showing the function of the COMPRESS system.  
 
None of the aforementioned systems have reached the clinical and regulatory maturity of the 
OPRA Implant System, which at the time of writing this thesis is the only system that has been 
granted a premarket approval in the USA.  
 
3.5. Benefits of bone-anchored attachment of prosthetic limbs 
With bone-anchored attachment of the prosthetic limb, the soft tissues in the residual limb are 
bypassed due to the elimination of the socket, and forces applied to the prosthesis are 
transferred directly to the skeleton. This leads to reduced energy dissipation and in individuals 
with transfemoral amputation it has been shown that bone-anchored attachment leads to a more 
efficient gait and reduced energy expenditure compared with socket attachment [48], [49]. For 
this patient group it has also been shown that bone-anchored attachment leads to improvement 
in quality of life, mobility, prosthesis usage, range of motion, sitting comfort, and reduced 
amputation- and prosthesis-related problems [48]–[55]. The rigid connection to the skeleton 
also provides mechanical stimuli to the bone which is needed to preserve the bone stock. 
Another positive consequence is osseoperception, which is the sensation arising from 
mechanical stimulation of a bone-anchored prosthesis [56]. Osseoperception is a multisensory 
perception involving tactile as well as auditory sensation. It has been shown that users with 
bone-anchored attachment of the prosthesis have improved ability to recognize vibrotactile 
information from the prosthesis compared with socket users [57], [58]. This may be particularly 
important for individuals with lower limb amputation since it increases the awareness of the 
surface structure of the ground and may potentially reduce the risk of falling. Bone-anchored 
attachment also leads to a faster and simpler donning and doffing procedure of the prosthesis 




3.6. Current OPRA Implant System 
The current version of OPRA Implant System, (Figure 5), consists of three components: (1) an 
externally threaded, cylinder-like, fully implanted “fixture”; (2) a percutaneous skeletal 
extension called “abutment”; and (3) an “abutment screw”. The proximal end of the abutment 
is press-fit into the distal end of the fixture and the distal end protrudes through the skin and 
allows for connection of the prosthesis. The abutment screw extends through the hollow center 
of the abutment to clamp the abutment and the fixture together by a preload via the proximal 
thread engagement to the fixture and the abutment screw head on the distal end of the abutment. 
For lower limb amputations, the fixture is implanted 20 mm countersunk into the bone as 
indicated in Figure 5. This is done to address the problem of distal bone resorption, which was 
sometimes observed when the fixture was placed flush with the distal bone end, and to reduce 
the risk of infection in the bone-fixture interface [59]–[61]. The system is designed to ensure 
that the abutment and abutment screw fracture before the fixture, or the bone, if exposed to 
excessive loads, since these components are more easily replaced than the osseointegrated 
fixture.  
 
Figure 5. OPRA Implant System and its individual components. 
 
 
3.7. Safety release Axor II 
The direct connection between the skeleton and the prostheses makes excessive loads 
hazardous with the risk of implant or bone fracture in case of a fall. To prevent such failures, 
the OPRA Implant System at the lower limb level is equipped with an external safety system. 
It is an intermediate connector between the percutaneous skeletal extension and the external 
prosthesis, and it automatically releases the connection in response to overloading. For 
transfemoral amputations, this system, known as the Axor II (Figure 6), has active release 
functions responding to overloads both in bending and in torsion. The release thresholds are 
set to ensure that no potentially harmful moments are transferred to the implant and the bone 
while at the same time being sufficiently high to prevent inadvertent release during activities 





Figure 6. Axor II, the safety release system to be used in combination with the OPRA Implant System at the 
transfemoral level. 
 
3.8. Current e-OPRA Implant System 
The e-OPRA Implant System (Figure 7) is an enhanced version of the OPRA Implant System, 
where the enhancement consists of a neuromuscular interface realized by implanted electrodes 
placed into/onto muscle tissue and around nerves in the residual limb [11], [12]. The e-OPRA 
Implant System is connected to the skeleton, muscles, and nerves within the residual limb and 
forms a neuromusculoskeletal interface. The percutaneous titanium implant is used as a 
permanent stable human-machine gateway for wired communication between muscles and 
nerves inside the body and the prosthesis external to the body. The implanted electrodes record 
myoelectric activity and this information is used to provide voluntary control of the prosthetic 
limb [11]–[15]. The system also supports communication in the opposite direction, where 
signals from pressure sensors on the external prosthesis may record contact of an object, and 
the system responds by providing electrical stimulation via the neural interface, eliciting a 





Figure 7. Schematic cross-sectional view of the e-OPRA Implant System. 
 
 
The structural components of the system, namely the fixture and the abutment, are unchanged 
from the OPRA Implant System whereas the e-abutment screw and the e-central screw have 
been modified with respect to their OPRA counterparts. Specifically, they have been equipped 
with in-line connectors which ensures a wired electrical connection from the implanted 
electrodes to the distal end of the abutment screw. The e-OPRA Implant System has preserved 
the modularity from the OPRA Implant System, which allows for replacement of individual 
components if needed. The e-OPRA Implant System was implanted for the first time in 2013 
in a 40-year-old man with transhumeral amputation [11]. He has since then been using the 
system continuously in his daily life. The system has also been implanted in five more 
individuals with upper limb amputation (four at the transhumeral level and one at the 
transradial level) as part of an ongoing clinical trial, and it has been shown that a prosthesis 
connected to the skeleton, nerves, and muscles, improves function and quality of life of people 
with upper limb amputations [12], [14], [16], [62]. The e-OPRA Implant System has no 
precedents in the field and is one of the most integrated bionic systems in the word. The 
collective experience leads to the expectation that this neuromusculoskeletal interface in 
combination with advanced leg prostheses, could provide significant improvements in 






3.9. Recent advancements in surgical techniques for improved prosthesis control 
A number of promising surgical techniques have been developed in recent years by which the 
amputated limb is surgically modified to increase the capacity for extraction of control 
information. One such example is targeted muscle reinnervation (TMR). As a result of an 
amputation, a nerve may be severed and deprived its muscular target. After being severed, the 
nerve may still carry motor control information but the small amplitude of the signals makes it 
difficult to use them for prosthesis control [63]. However, by redirecting the severed nerve to 
a new target muscle, the nerve will innervate the muscle which will in turn serve as a biological 
amplifier of the motor control information that is sent via the nerve. The EMG signals can be 
recorded by electrodes and may thus be used for prosthesis control. For successful results, the 
new target muscle should be denervated from other motor nerves which may otherwise 
generate unwanted EMG signals which can confound prosthesis control [63]. TMR was first 
clinically implemented by Kuiken et al. in 2003 on an individual with bilateral shoulder 
disarticulation [64]. The method has also been used for prosthesis control in individuals with 
lower limb amputation [35]. TMR is also investigated for treatment of painful neuromas which 
may arise as a result of an amputation [63].   
 
A related surgical technique is the regenerative peripheral nerve interface (RPNI) [65]. With 
this method, a transected peripheral nerve or peripheral nerve fascicle is implanted into a free 
muscle graft [66]. After undergoing reinnervation by the nerve and revascularization, the 
muscle graft functions as a bio amplifier to produce myoelectric activity which can be recorded 
with implanted electrodes and used for prosthesis control. Since free muscle grafts are used, 
and due to the fact that the nerve may be split into several fascicles, each implanted into a 
separate muscle graft, RPNIs may provide a larger number of EMG signal sources for 
prosthetic control compared with TMR.  
 
A third recently developed surgical technique is known as agonist-antagonist myoneural 
interface (AMI). With this technique agonist-antagonist muscle pairs are created within the 
residual limb. The muscle pairs are created so that a contraction of the agonistic muscle induces 
tension of the antagonistic muscle and vice versa. The muscle stretch generates proprioceptive 
information which in addition to EMG signals used for prosthetic control can provide 












4. Design input 
4.1. Systematic literature review – Paper I 
As part of the design input phase of this thesis project, the design features and biomechanical 
characteristics of known implant systems for bone-anchored attachment of limb prostheses 
were studied in detail in a systematic literature review [47] (Paper I). All the studied systems 
had shown some level of clinical success, defined as successful loadbearing function for at 
least one year after implantation. A common feature for the implant systems is that they all use 
intramedullary implants. However, large differences were found in how primary and secondary 
stability was achieved. For the primary stability, defined as the immediate stability before 
healing and osseointegration, one of three strategies were used: a threaded connection (OPRA), 
axial compression (COMPRESS), or a press-fit connection (the rest of the systems). For the 
secondary stability, all implant system used variations of porous surfaces for bone ingrowth. 
Regarding the implant material, all studied systems used the titanium alloy Ti6Al4V as the 
bulk material, except for the ILP which uses a cobalt chromium molybdenum alloy. A 
comparison of material and interface characteristics between the systems is presented in Table 
1.   
 
Table 1. The table (adapted with permission from Thesleff et al. [47] (Paper I)) shows a comparison of material 
and interface characteristics of bone-anchored implant systems for direct skeletal attachment of external limb 
prostheses. 
  Interfaces 
System Material Bone – Implant Implant – Percutaneous 
part 
Percutaneous part – Soft 
tissue 
OPRA Ti6Al4V Thread Press-fit and locking screw Polished 
ILP CoCrMo  Press-fit Press-fit and locking screw Polished 
OPL Ti6Al4V Press-fit Press-fit and locking screw Polished 
ITAP Ti6Al4V Press-fit - Perforated flange / Polished  
POP Ti6Al4V Press-fit Press-fit and locking screw Ceramic coating 
COMPRESS Ti6Al4V 
Transverse pins / 
Axial compression 
Taper connection Porous titanium / Polished 







This section provides a brief introduction to bone tissue and the femur with regards to its 
mechanical properties and structural capacity. This is followed by a short description of 
potential implant materials and their characteristics in terms of mechanical properties, 
biocompatibility, and durability.    
  
4.2.1. Bone tissue 
Bone tissue is the hard organic compound from which our skeletons are made and its basic 
function is to provide structural support for our bodies. At a macroscopic level, the material 
bone is divided into two categories: trabecular bone, also commonly referred to as cancellous 
or “spongy” bone, and cortical bone, also known as compact bone. These two types of bone 
have the same material building blocks, a mineral phase which mainly consists of 
hydroxyapatite, an organic phase with collagen type-I as the major constituent and water. What 
distinguishes cortical bone from trabecular bone is the structure and the porosity of the material. 
Trabecular bone has a high porosity, typically 75-95% [72] and the structure can be described 
as a porous bone matrix of interconnected plates and struts. Cortical bone instead is a compact 
material and has a much lower porosity, normally about 5-10% but increases with age and 
osteoporotic diseases [72]. As a result of their different structure and porosity, the two bone 
types exhibit large differences in their macroscopic mechanical behavior. Because of its 
compact structure, cortical bone is much stiffer and stronger than trabecular bone, whereas 
trabecular bone may deform more before fracturing.  
 
4.2.2. Bone remodeling 
Bone is not a static tissue but is continuously undergoing changes as the result of the interplay 
between bone resorption, where bone tissue is removed, and new bone formation. The result 
from these competing processes is called bone remodeling. The remodeling process is 
dependent on mechanical loading, where new bone formation and bone resorption is regulated 
in response to the loads that the bone has to withstand. It can be viewed as an optimization 
process, where the objective is to minimize the weight, while being sufficiently strong to safely 
withstand repeated external loads. If the mechanical stimuli are low, resorptive activity will 
dominate to reduce the bone mass, leading to net bone loss. If on the other hand, the bone 
receives high repeated mechanical stimuli, new bone formation will dominate and increase the 
bone mass until a bone homeostasis is reached. 
 
4.2.3. Mechanical properties of bone 
On a macroscopic level, trabecular bone has isotropic material properties whereas cortical bone 
can be adequately modelled with orthotropic or transversely isotropic material properties. Bone 
is a viscoelastic material and thus has rate dependent material properties. At high strain rates 
bone is stiffer and stronger than at low strain rates. Wolfram and Schwiedrzik in 2016 published 
a review of prior reseaerch studies, reporting experimentally measured yield and ultimate 
strength and strain of human cortical bone [73]. From  these studies ultimate strengths of 54–




respectively. Reported values for the ultimate shear strength in the longitudinal direction have 
been 29–68 MPa according to the same literature review [73]. The ranges come from 23 
different studies with variations in experimental conditions and test specimens. In Table 2, the 
experimentally determined mechanical properties of human cadaver femora from two of the 
included studies are presented. 
 
Table 2. Experimentally measured properties for human femur cortical bone. E denotes the elastic modulus. G 
denotes shear modulus. ν denotes Poisson’s ratio. σ denotes ultimate normal stress. τ denotes ultimate shear 
stress. Subscripts L, and T, denotes the longitudinal direction and the transverse plane respectively. 
Author & Year Test specimens & Test method Material properties Ultimate strength 
Reilly 1975 [74] Human femur 
Uniaxial testing at 2-5%/s 
Torsional testing (rate not stated) 
EL = 17 GPa 
ET = 11.5 GPa 
GLT = 3.28 GPa 
νTT = 0.58 
νLT = 0.46 
σL Tension = 133 GPa 
σL Compression  = 193 GPa 
σT Tension  = 51 GPa 
σT Compression = 133 GPa 
τLT = 68  GPa 
Dong 2004 [75] Human femur 
Uniaxial testing at 0.1%/s 
Torsional testing at 1°/s 
EL = 16.61 GPa 
ET = 9.55 GPa 
GLT = 4.74 GPa 
νTT = 0.46 




The strength and the Young’s modulus (elastic modulus in tension) for trabecular bone is 
highly dependent on the porosity and apparent density, therefore it is difficult to set a well-
defined value for the strength, and the Young’s modulus, but mid-range values as design goals 
for replacement materials of trabecular bone are 5-10 MPa strength and 50-100 MPa Young’s 
modulus according to Yaszemski et al. 1996 [76]. 
 
4.2.4. Bending and torsional strength of the femur 
The bending strength of femur has been determined in a number of studies on human cadaver 
bones using 3-pt bending and 4-pt bending tests in quasistatic or dynamic conditions. The 
reported failure moments at the diaphysis range from 125–202 Nm and 185–310 Nm in 
quasistatic conditions for females and males respectively. For dynamic conditions, the reported 
failure ranges are 298–435 Nm and 355–605 Nm for females and males, respectively [77], [78]. 
Fewer studies have been performed to determine the torsional strength of the femur, however 
Robertson et al. 2007 [79] reported a torsional strength of 132 ± 33 Nm for intact femurs in an 
experimental study on 12 femurs (5 female, 7 male, age 59 ±16 years). 
 
4.2.5. Orthopedic implant materials 
Materials for orthopedic implants must be biocompatible due to their permanent implantation 
in the body. The human body is a corrosive environment and thus a high corrosion resistance 
is imperative. For loadbearing implants, a high strength and fatigue resistance is also important 
to prevent implant failure. Most loadbearing implants have a much higher Young’s modulus 




where the implant shields the bone tissue from experiencing the stresses associated with typical 
loading with a potential consequence of bone resorption and reduced bone density. To prevent 
this from happening, a low Young’s modulus is desired. For modular implants, the wear 
resistance is also important since wear debris from contact surfaces may cause adverse local 
tissue reactions, resorption and aseptic loosening of the implant [80]–[82]. A good resistance 
to wear and a related phenomenon known as fretting is also necessary to preserve the stability 
in static connections between the implanted components. Fretting is defined as small amplitude 
oscillatory movement between contacting surfaces that are nominally at rest [83]. The relative 
movement may lead to fretting corrosion by disruption of protective passive oxide films of the 
surfaces and thereby make them more susceptible for corrosion [80]. The damage from the 
fretting action accelerates nucleation and early growth of fatigue cracks, reducing the 
mechanical strength and durability under continued loading [83]. The aforementioned desired 
characteristics limits the number of materials that are suitable for loadbearing orthopedic 
implants. The most commonly used materials are, commercially pure titanium or titanium-
based alloys, cobalt-chromium-based alloys or stainless steel 316L [84]. These materials are 
briefly discussed below.  
 
4.2.5.1. Stainless steel 
Steel has a density of approximately 8000 kg/m3 and a Young’s modulus of 200 GPa. Only 
austenitic and precipitation hardened stainless steels are used in orthopedic applications [84]. 
Most widely used is AISI 316L which is an austenitic stainless steel where ‘L’ indicates low 
carbon content (< 0.03 %). Despite good biocompatibility, high strength and relatively low cost 
this type of steel is not as popular as titanium-based and cobalt-chromium-based alloys for 
permanent loadbearing implant applications [85].  
 
4.2.5.2. Titanium and titanium-based alloys 
Titanium is a very bioinert material due to a highly corrosion-resistant oxide layer which is 
rapidly formed on the titanium surface. Other desirable features of titanium are the relatively 
low values of Young’s modulus (115 GPa) and density (4500 kg/m3) compared with steel and 
cobalt-chromium alloys. Titanium is also known for its excellent capacity for osseointegration. 
Both commercially pure titanium and titanium alloys are used for orthopedic implants. For 
applications requiring a high strength, the alloy Ti6Al4V (Al and V stands for aluminum and 
vanadium respectively) is most popular, due to its high yield and tensile strengths (yield 
strength ≥ 795 MPa and tensile strength ≥ 860 MPa [86]).   
 
4.2.5.3. Cobalt-chromium based alloys 
Of the cobalt-chromium-based alloys, CoCrMo (Mo stands for molybdenum) is the one which 
is most commonly used for loadbearing orthopedic implants. The excellent corrosion resistance 
and high strength (yield strength minimum 827 MPa and tensile strength minimum 1192 MPa 





4.3. Loading of the bone-anchored implant 
High impact loads of magnitudes approaching the yield strength of the bone or the implant are 
prevented from reaching the implant by the external safety release system. However, it is 
crucial that the thresholds of the safety release mechanism are sufficiently high so that it does 
not release during intentional loading. Forces and moments under the thresholds, are 
transferred to the implant system and could potentially lead to fatigue of the implant or the 
bone if stress levels / load cycles exceed what the material can withstand. The loads may also 
influence remodeling of surrounding bone tissue which could affect implant and bone integrity 
over time.  
 
4.3.1. Load measurements during everyday ambulatory activities – Paper II 
To quantify the loading of the bone-anchored implant, a number of research studies have 
performed direct load measurements at the interface between the abutment and the prosthesis 
in individuals with the OPRA Implant System at the transfemoral level [88]–[92]. The most 
extensive dataset was collected within the scope of this thesis in Paper II [92] where load 
measurements were conducted on 20 individuals with the OPRA Implant System while 
performing everyday ambulatory activities. A summary of the obtained load data is presented 
in Table 3.  
 
Table 3. Average (across research participants) peak (magnitude) force, and moment, during everyday 
ambulatory tasks from the study described in Paper II [92]. FA, FML, FL denotes the peak forces along the anterior-
posterior, medio-lateral and inferior superior directions respectively. MA, MML, ML denotes peak moments in the 
anterior-posterior, medio-lateral, inferior-superior directions respectively. MB denotes the peak bending moment. 
 Walk Slope Ascent Slope Descent Stairs Ascent Stairs Descent 
FA [N] 101 106 93.6 77.2 102 
FML[N] 75.2 69.7 66.8 67.1 54.9 
FL [N] 625 582 596 656 516 
MA [Nm] 30.7 27.4 27.4 24.3 19.7 
MML [Nm] 18.7 18.8 20.4 20.9 20.1 
ML [Nm] 5.28 5.34 4.03 5.08 4.06 
MB [Nm] 36.7 34.5 35.4 33.0 32.2 
  
 
4.3.1.1. Conclusions from Paper II 
• Given the magnitudes of the measured forces and moments, the bending moment 
contributes the most to the overall stress state in the bone-anchored implant and 
surrounding bone.  
  
• With reference to level ground walking, no activity generated statistically significantly 
higher bending moments on the bone-anchored implant and only stair ascent generated 
statistically significantly higher resultant force. For the majority of the research 
participants, the loads generated during level ground walking were of similar magnitude 
as the loads generated during other activities.  
 





• Using a crutch in the contralateral hand during level ground walking on average led to 
10 % reduction in the maximum resultant force and 13 % reduction in the maximum 
bending moment across the research participants. 
 
4.3.2. Loads during running – Paper III 
With a stronger implant system, the limitations on what activities the user may perform could 
be reduced. One activity which is currently advised against is running. Running is a cyclic 
activity, causing repetitive loading on the implant and the bone. For long distance runners the 
number of load cycles may be large and could thus potentially lead to fatigue of the implant or 
the surrounding bone. The load exposure of the implant and the bone during running is not 
known. Load measurements from a similar scenario but with a distal femoral replacement 
rather than an implant for attaching a limb prosthesis was reported in a case study by Taylor 
and Walker in 2001 [93]. The distal femoral implant was instrumented to measure axial force, 
torque, and bending moments in the prosthesis shaft. The maximum reported load magnitudes 
for the study participant who weighed 70 kg, were 73 Nm and 51 Nm around the antero-
posterior and medio-lateral axes, respectively, and 8.8 Nm torsional moment during jogging at 
1.70 - 1.92 m/s. In another study by Taylor et al. in 2020 [94], an attempt was made to estimate 
the loads based on inverse dynamics from kinetic and kinematic data from able bodied 
participants running at self-selected speed. In that study, the average peak moments during 
running were approximately 140 Nm and 8 Nm in bending and torsion, respectively.  
Due to the limited data and the fact that, for safety reasons, it is not possible to do direct 
measurements on the existing cohort of current users of OPRA Implant System during running, 
it was decided to conduct a simulation-based study to estimate the forces during running. A 
musculoskeletal simulation study was therefore performed using the publicly available 
software OpenSim [95]. Starting from a musculoskeletal model developed by Hamner et al. 
2010 [96], an adapted model was created, where the lower limb segments and musculature 
were adapted to simulate an individual with a transfemoral amputation treated with a bone-
anchored prosthesis. A non-articulated joint was created at the bone-implant interface to allow 
for force and moment data extraction. Following the OpenSim workflow (Figure 8), the 
adapted model was scaled and matched with a kinematic and ground reaction force dataset 
obtained from the study by Hamner et al. [96], where an able-bodied participant was running 
at 3.96 m/s on an instrumented treadmill. Using the OpenSim procedures of residual reduction 
algorithm, static optimization and joint reaction analysis, the loads at the simulated bone-





Figure 8. Procedures in the simulation-based investigation to determine the loads at bone-anchored implant 
during running [97] (Paper III). The original musculoskeletal model and the dataset of an able-bodied 
individual performing a running trial on an instrumented treadmill were obtained from Hamner et al. [96]. By 
replacement and adjustment of lower limb segments and musculature of the amputated side, an adapted model 
simulating an individual with a transfemoral amputation treated with a bone-anchored prosthesis was created. 
A non-articulated joint was created at the bone-implant interface to allow for force and moment data extraction. 
The OpenSim workflow was performed in sequence as indicated. Details about each step of the procedure is 
available in Paper III [97]. 
 
4.3.2.1. Results from Paper III 
The results from the joint reaction analysis are presented in Figure 9 and in more detail in Paper 






Figure 9. Force and moment data extracted at the bone-implant interface during a running gait cycle in Paper 
III [97]. The forces and moments are presented in the local coordinate system of the bone-anchored implant in 
the left leg of the musculoskeletal model. The x-direction denotes the local anterior direction, the y-axis denotes 
the longitudinal direction of the bone-anchored implant (coincident with the longitudinal direction of the femur 
at the level of the amputation). The z-axis denotes the medial direction of the bone-anchored implant.  
 
4.3.2.2. Conclusions from Paper III 
 





• The model has several limitations which may affect the accuracy of the results. 
Examples of limitations are: 
o Uncertainties in the accuracy of the adapted model with respect to inertial 
properties of adapted leg segments, removal and adjustment of muscles 
trajectories and muscle properties). 
o Inherent uncertainty of using inverse dynamics for calculation of forces and 
moments at proximal joints. 
o Data set from able-bodied individual was used to calculate forces and moment 
in a model of a subject with transfemoral amputation. 
o Residual (nonphysical) forces and moments were required to fulfill Newton’s 
second law of motion while keeping trajectory errors at minimum. 
 
• The maximum torsional moment at the bone-anchored implant in the simulation was 
100 Nm. This is an order of magnitude higher than the torsional moments reported 
during jogging and running in the studies by Taylor and Walker [93] and Taylor et al. 
[94], and during walking in Thesleff et al. [92], Lee et al. [88] and Frossard et al. [90]. 
Due to the uncertainty and potential sources of errors listed above, the results from this 










5. Implant design 
Safety was the highest priority in the implant design process. Therefore, efforts were made to 
preserve features from the OPRA Implant System that had proved to be well-functioning and 
had shown good results clinically. It was also decided to preserve the modularity of the system 
to ensure that a single failed component would not risk the entire system. Following concept 
generation and brainstorming sessions, potential implant system concepts were modelled in 
CAD for further evaluation. The concepts were subsequently evaluated in terms of mechanical 
strength using Finite Element Analysis (FEA). This was performed in an iterative process 
where the effect of specific design features was investigated to achieve an optimal implant 
system design. As part of this evaluation, a parametric study was performed to quantify the 
structural effects of dimensional changes of the thread profile and the cortical thickness of the 
surrounding bone [98] (Paper IV).  
 
5.1. Parametric Finite Element Evaluation – Paper IV  
The objective of the study was to perform a parametric evaluation on the effect of thread profile 
parameters and cortical thickness, on the peak stress and strains in a generic implant model 
subjected to external loads corresponding to average and high ambulatory loading. An 
additional aim was to quantify effects of changes in bone stiffness characteristics and distal 
bone resorption on the maximum stresses in the implant system. The generic model geometry 
and the investigated parameter space is presented in Figure 10. 
 
 
Figure 10. Generic geometry and the investigated parameter space in [98] (Paper IV). The parameters 






5.1.1. Conclusion from Paper IV 
 
• Of the investigated parameters the cortical thickness had the largest effect on stress and 
strain in the cortical bone and the fixture. At loads corresponding to high loading 
ambulation, 5 mm of cortical bone thickness led to approximately 40 % lower 
maximum longitudinal stresses at the central half of the fixture compared with a cortical 
thickness of 2 mm. 
 
• Changes in thread depth had larger effect on the maximum stresses in the fixture and 
the bone than changes in thread root radius within the evaluated parameter space.  
 
• Stress reductions in the abutment were obtained by autologous transplantation of bone 
tissue distal to the fixture.  
 
• A reduction in the longitudinal Young’s modulus of the cortical bone had a larger 
relative effect on the maximum stress in the fixture at a large cortical thickness than at 
a small cortical thickness.  
 
• Severe distal bone resorption, to an extent which leaves a portion of the distal fixture 
without support from cortical bone, may lead to more than 50 % increase in the 
maximum stress in the fixture as compared with a scenario with full support of cortical 







6. Structural and functional verification 
Both static and dynamic testing of prototypes have been performed within this thesis project. 
The aims of this testing were both to determine the ultimate strength of the system and to 
determine the load limits during fatigue loading.  
Unfortunately, no standard exists for testing of bone-anchored implants for attachment of limb 
prostheses. For the endurance tests, a modified version of a standard developed for endurance 
testing of the neck region of stemmed femoral components in hip implants has therefore been 
followed [99].  
At the writing of this thesis, the full series of endurance tests has not been completed. However, 
preliminary results are encouraging and indicate substantial improvements in load capacity 
compared with current version of the OPRA Implant System. 
 
6.1. Evaluation of surface enhancement method – Paper V 
As part of the structural verification, a potential surface enhancement method for improved 
fretting resistance was experimentally evaluated [100] (Paper V). Fretting corrosion and 
fretting fatigue are known problems of modular orthopedic implants both due to negative tissue 
reactions from the wear debris and due to premature fractures of the implant itself as a result 
of the fretting degradation [80]–[82]. The investigated surface enhancement method, known as 
low plasticity burnishing (LPB), introduces compressive residual stresses in the treated region. 
These compressive stresses act against tensile loads and may thereby prevent or delay crack 
initiation from fretting or fatigue. The surface enhancement method was evaluated on a version 
of the first generation of the OPRA Implant System rather than on the new version of the 
implant system, since this method may be applicable also for this older version of the implant 
system in order to prolong fatigue life and improve fretting resistance. 
The tested components, a schematic illustration of the surface enhancement process, and the 







Figure 11. The figure is from [100] (Paper V) and shows the following: (A) Tested components, (B) A schematic 
illustration of the LPB process (adapted with permission from Prevéy and Telesman 2000  [101]), (C) A 
schematic illustration of the rotation bending test setup. 
 
The test components were divided into a Control group and an LPB group of which the 
abutments in the latter group underwent LPB processing. The test components were 
assembled into test specimens before undergoing rotation bending fatigue tests. Following the 
tests an analysis of the contacting surfaces was conducted using optical microscopy, scanning 
electron microscopy (SEM) and interference profilometry. The results from the rotation 







Figure 12. Boxplot showing the number of load cycles in the rotation bending tests [100] (Paper V). Each test is 
denoted with a black “x”. The median is denoted with a horizontal red line. 
 
6.1.1. Conclusions from Paper V 
 
• Rotation bending fatigue tests performed on LPB treated and untreated test specimens 
demonstrate that the LPB treatment leads to statistically significantly increased 
resistance to fretting fatigue (LPB treated test specimens withstood on average 108 
780 load cycles as compared with 37 845 load cycles for untreated test specimens, p = 
0.004).  
 
• LPB treated test specimens exhibited less wear at the modular interface as compared 
with untreated test specimens.  
 
• The LPB surface treatment may lead to reduced risk of fretting induced component 










7. Preparation for clinical implantation 
Within the scope of the thesis, the first steps towards clinical implantation have been taken. A 
research protocol has been developed for assessing the ability of the neuromusculoskeletal 
interface to facilitate bidirectional communication between muscles and nerves within the 
residual limb and the external prosthesis. Specifically, it will be assessed whether myoelectric 
activity recorded via the neuromusculoskeletal interface can be used to control a lower limb 
prosthesis and whether sensations perceived in the missing limb can be elicited to provide 
sensory feedback from the prosthesis. The research study will also assess whether the 
neuromusculoskeletal interface may lead to functional improvements in individuals with lower 
limb amputation. Risk analyses have been performed to minimize the risks not only with the 
surgical aspects, and clinical use of the neuromusculoskeletal interface, but also on the research 
activities to be performed within the clinical investigation. The neuromusculoskeletal interface 
has never been used in the lower limb or in combination with active lower limb prosthetic 
components. Furthermore, compared with research and testing of upper limb prostheses, 
research and testing of lower limb prostheses is inherently more hazardous due to the risk of 
falling and subsequent injuries [102]. To address this, a stepwise safety protocol has been 
developed for the research scenarios involving the recipient(s) of the neuromusculoskeletal 
interface within the clinical investigation [103] (Paper VI).  
 
7.1. Stepwise safety protocol for lower limb prosthetic risk management in a 
clinical investigation – Paper VI 
The safety protocol was developed to evaluate neuromusculoskeletal prostheses for the lower 
limb but it can be applied to any new leg prostheses and control strategies. To minimize the 
risks for the research participants, a number of safety levels have been defined (Figure 13). 
Every time a new or modified prosthesis is to be implemented with a research participant, the 
stepwise safety protocol must be followed, starting from the highest safety level. Each safety 
level has at least one test method with required outcome(s) that must be met before advancing 
to the next lower level (or sub-level). Specific precautions during ambulation, including 





Figure 13. The figure is from [103] (Paper VI) and shows the stepwise safety protocol. From left to right the columns denote: (1) Test environment applicable for each safety 
level, (2) Type of participant applicable for each safety level, (3) Type of safety aid to be used and whether dual tasks are to be performed, at each safety level. (4) Stepwise 
safety levels, (5) Examples of test methods to be performed at each safety level, (6) Required outcome to be achieved before progression to the next lower safety level is 




8. Summary of thesis contributions 
Within the scope of this thesis, a new design of the neuromusculoskeletal interface for neural 
control and sensory feedback of bone-anchored lower limb prostheses has been developed. The 
new design has an improved structural capacity compared with current OPRA Implant System 
and facilitates the translation of the e-OPRA technology to amputations of the lower limb. 
Furthermore, the first steps towards clinical implantation of the system within a clinical 
investigation have been taken by development of a clinical research protocol that has been 
approved by the Swedish Ethical Review Authority. Contributions from individual papers are 
summarized below.  
 
Paper I 
Paper I provided a review of literature on implant systems for bone-anchored attachment of 
limb prostheses. The review was focused on the mechanical features of the implant systems, 
their interfaces with surrounding biological tissue, and their design characteristics, in contrast 




Paper II presented the largest set of load data for individuals treated with bone-anchored 
prostheses, regardless of amputation level, implant system, and measurement technique. The 
load data, measured directly at the bone-anchored implant during daily walking activities, can 
be used as input for further development of implant system designs, and clinically relevant 
methods for testing of this type of implant systems. Within this work it was further investigated 
how the use of walking aids affect the load levels at the bone-anchored interface. This 
information is crucial for understanding how to reduce the risk of mechanical complications 
with this type of prosthetic attachment, and it may also guide rehabilitation protocols both for 
the aggregate population and individually tailored for specific patients.  
 
Paper III 
Paper III provided the first evaluation of the anticipated loads at the bone-anchored interface 
during running. Knowledge of the load characteristics at the bone-implant interface during 
high-loading activities is scarce. However, this information is needed to understand the 







In Paper IV Finite Element Analysis was used to investigate the effects of thread profile 
parameters, cortical thickness, and bone stiffness characteristics for the stress and strains 
generated in bone-anchored implants and surrounding bone tissue. The study was conducted 
using a parameterized model of a bone-anchored implant system and surrounding bone to 
ensure wide applicability of the results and to generate knowledge on how to optimize the 
design in further developments of these systems. 
 
Paper V 
Paper V presented results from an experimental investigation of a surface enhancement method 
to improve the fretting resistance of bone-anchored implants for attachment of limb prostheses. 
The results from the study concluded that substantial improvements are achievable which may 
translate into increased service life, reduced need for component replacements, and increased 
loadbearing capacity for this and similar applications. 
 
Paper VI 
Paper VI presented a stepwise safety protocol for managing the risks when conducting research 
on active prosthetic legs, with modifiable control systems. The protocol can be applied to any 
new leg prosthesis or control system for controlling a lower limb prosthesis. It may serve as a 
reference for safety precautions to consider when conducting research and development of 






9. General conclusions and future work 
Extensive research has shown the benefits of bone-anchored attachment of lower limb 
prostheses and the maturity and clinical acceptance of this technology is increasing. 
Developments in implant system design, surgical procedures and external safety devices have 
reduced the rate of mechanical failure and infectious complications. The work in this thesis 
may potentially contribute to a continuation of this trend by further reduction of mechanical 
complications and reduced restrictions on high loading activities. Previous work has shown 
that the bone-anchored implant may serve as a mechanically stable human-machine gateway 
which allows for permanent use of implanted electrodes with percutaneous leads and that this 
may be used to provide intuitive prosthesis control and sensory feedback for individuals with 
upper limb amputation. The translation of this technology to lower limb amputations is 
currently underway, aided by the development of the neuromusculoskeletal interface within 
this thesis. It is hypothesized that this technology will allow for intuitive prosthesis control, 
sensory feedback, and functional improvements also for individuals with lower limb 
amputation. The neuromusculoskeletal interface provides a unique platform for harnessing the 
underexploited control information of muscles and nerves in the residual limb. A number of 
promising surgical techniques have been developed in recent years by which the amputated 
limb is surgically modified to increase the capacity for extraction of control information. TMR, 
RPNI and AMI are all very well suited for use in combination with the neuromusculoskeletal 
interface.  
However, before this can be explored, verification testing of the developed 
neuromusculoskeletal interface must be completed to ensure safety and adherence to regulatory 
requirements. The efficacy of the neuromusculoskeletal interface should then be assessed in 
controlled research studies within a clinical investigation.  
The function of the neuromusculoskeletal interface is limited to providing direct connection 
between the skeleton, nerves and muscles and the external prostheses. Thus, results in outcome 
measures evaluating prosthetic function for the user are not exclusively determined by the 
performance of the neuromusculoskeletal interface. The functional outcome will also be 
affected by clinical aspects such as the pre-surgery condition, anatomy, surgical outcome and 
rehabilitation. The functional outcome will also depend on the algorithms used for controlling 
the prosthesis, the prosthetic hardware to facilitate the intended movements and the ability to 
provide adequate sensory feedback. A clinical investigation must consider all these aspects and 
be carefully planned to minimize the risk for the research participants while objectively 
exploring the new opportunities for lower limb prosthesis control. The ultimate aims are to 
improve the quality of life for the users, to reduce the disability of the amputation and to pave 
the way for clinical translation.  
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